February 18, 2014
Drug manufacturers have a responsibility to ensure the safety of medications they release to the market. Failure to do so can result in patients suffering serious harm, which can lead to lawsuits being filed against the drug maker for damages.
Such a case has been filed in connection to patients suffering a specific Pradaxa Drug Injury, allegedly because the company who made the product failed to warn consumers of certain risks associated with the drug. Now, court documents are showing research that showed the dangers of Pradaxa may have been withheld due to the fact it could harm the marketability of the drug.
An article from the New York Times states the medication was one of several drugs looking to fill a gap in the market for medications used to prevent blood clots from forming in the body. The manufacturer stated it was a better blood clot treatment, as it did not require constant monitoring of blood levels to ensure proper levels of the drugs were being absorbed into the body.
The medication was distributed to 850,000 patients and resulted in an estimated 1,000 deaths due to a risk of uncontrollable bleeding associated with the drug. Lawsuits were filed in connection to the accidents.
Now, court documents are showing researchers may have knew about the dangers, but drug manufacturer executives may have hidden the results. The company has denied the allegations.
The Drug Injury Attorneys with Ferrer Poirot Feller Daniel recognize the dangers posed by drug manufacturers withholding vital information about a product and are here to help anyone who has been harmed as the result of taking a medication prescribed by a doctor.